Curaleaf Holdings (CURLF) Times Interest Earned (2019 - 2025)
Curaleaf Holdings (CURLF) posted quarterly Times Interest Earned of $0.03 for Q4 2025, down 99.8% year-on-year from $17.54 in Q4 2024, and down 99.8% on a QoQ basis from $17.54 in Q4 2024.
Curaleaf Holdings (CURLF) Times Interest Earned (2019 - 2025) Analysis & Trends
Curaleaf Holdings (CURLF) has reported Times Interest Earned for 7 consecutive years, with $0.03 the latest figure, recorded in Q4 2025.
- Quarterly Times Interest Earned fell 99.8% year-over-year to $0.03 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $0.09 (down 96.45% YoY) and the FY2025 annual result came in at $0.04, down 26.42% from the prior year.
- Times Interest Earned fell to $0.03 in Q4 2025 per CURLF's latest filing, from $17.54 in the prior quarter.
- Over the last five years, Times Interest Earned for CURLF reached as high as $108.73 in Q1 2021 and fell as low as $0.0 in Q4 2023.
- A 5-year average of $21.68 and a median of $6.68 in 2022 frame the typical range for Times Interest Earned.
- Annual changes were most pronounced in 2023 — Times Interest Earned slumped 100.0% — and 2024, when it jumped 9469673.99%.
- Year by year, Times Interest Earned stood at $1.29 in 2021, then surged by 260.0% to $4.65 in 2022, then sank by 100.0% to $0.0 in 2023, then soared by 9469673.99% to $17.54 in 2024, then tumbled by 99.8% to $0.03 in 2025.
- According to Business Quant data, Times Interest Earned over the past three periods registered $0.03, $17.54, and $1.84 for Q4 2025, Q4 2024, and Q3 2024 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 13.44 |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -2.81 |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 0.18 |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -0.07 |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 0.33 |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 5.11 |
| 10 | Curaleaf Holdings | 7.13 Bn | 7.13 Bn | 157.29 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 0.03 |
| Dec 31, 2024 | 17.54 |
| Sep 30, 2024 | 1.84 |
| Dec 31, 2023 | 0.00 |
| Sep 30, 2023 | 17.05 |
| Dec 31, 2022 | 4.65 |
| Sep 30, 2022 | 8.71 |
| Sep 30, 2021 | 1.29 |
| Jun 30, 2021 | 56.96 |
| Mar 31, 2021 | 108.73 |
| Dec 31, 2020 | 1.17 |
| Sep 30, 2020 | 1.62 |
| Jun 30, 2020 | 2.22 |
| Mar 31, 2020 | 0.60 |
| Dec 31, 2019 | -4.00 |